A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01139593

Enrollment

128

Registered

2010-06-08

Start date

2010-06-30

Completion date

2015-12-31

Last updated

2015-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

IVF, ICSI, gonadotropin, am dose, pm dose, pregnancy, implantation, live birth

Brief summary

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

21 Years to 42 Years

Healthy volunteers

Inclusion criteria

* women between 21-42 undergoing IVF

Exclusion criteria

* women \> 45, * women with one ovary, * donor egg, * surrogacy, * FET cycles, * uterine problems, * large fibroids

Design outcomes

Primary

Measure	Time frame
Live birth rate	4 years

Countries

United States

Outcome results